Stellaromics is a Boston-based company that has developed in situ spatial multi-omics technology to accelerate the development of novel drug treatments.

Corsair Pharma is a biopharmaceutical company that is developing a transdermal treprostinil prodrug patch to improve medication therapeutic profiles and provide treatment options for patients with PAH.